| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/08/1999 | WO1999033870A2 Human regulatory proteins |
| 07/08/1999 | WO1999033869A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 07/08/1999 | WO1999033522A2 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancer |
| 07/08/1999 | WO1999033485A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 07/08/1999 | WO1999033484A1 Production process for intravenous immune serum globulin and resultant product |
| 07/08/1999 | WO1999023228B1 Svph1-26 dna and polypeptides |
| 07/08/1999 | WO1999021574A3 Enhancement of morphogen activity |
| 07/08/1999 | WO1999014357A9 Reagents and methods useful for detecting diseases of the prostate, breast and ovary |
| 07/08/1999 | WO1999004265A9 Cancer associated nucleic acids and polypeptides |
| 07/08/1999 | CA2317120A1 Use of a phosphatidylserine/polypeptide conjugate for inducing autoimmunity in the treatment of cancer |
| 07/08/1999 | CA2317029A1 A method of isolating a peptide which immunologically mimics microbial carbohydrates including group b streptococcal carbohydrates and the use thereof in a vaccine |
| 07/08/1999 | CA2316545A1 Novel nucleic acid and polypeptide with homology to the tnf-receptors |
| 07/08/1999 | CA2316397A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 07/08/1999 | CA2316079A1 Human regulatory proteins |
| 07/08/1999 | CA2316017A1 Reagents and methods useful for detecting diseases of the breast |
| 07/08/1999 | CA2316016A1 V197 dna and polypeptides |
| 07/08/1999 | CA2315977A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 07/08/1999 | CA2315944A1 Bifunctional molecules |
| 07/08/1999 | CA2315879A1 V201 dna and polypeptides |
| 07/08/1999 | CA2315702A1 V196 dna and polypeptides |
| 07/08/1999 | CA2315617A1 Human signal peptide-containing proteins |
| 07/08/1999 | CA2315252A1 Essential bacterial genes and their use |
| 07/08/1999 | CA2281938A1 Production process for intravenous immune serum globulin and resultant product |
| 07/08/1999 | CA2240798A1 Method for induction of differentiation of osteoclasts |
| 07/07/1999 | EP0927763A2 Novel aroA |
| 07/07/1999 | EP0927760A2 Immunreactive parts of the glycoproteins gpII from Varicell-Zoster-Virus |
| 07/07/1999 | EP0927759A2 Immunoreactive protein VP26 of Varicella Zoster Virus (VZV) and its diagnostic use |
| 07/07/1999 | EP0927758A2 Recombinant antibodies specific for TNF-Alpha |
| 07/07/1999 | EP0927354A1 DIAGNOSTIC METHOD FOR DETECTION OF MOLECULAR FORMS OF EOSINOPHILIC CATIONIC PROTEIN (iso-ECPs) |
| 07/07/1999 | EP0927266A1 THE $i(ESCHERICHIA COLI csrB) GENE, RNA ENCODED THEREBY, AND METHODS OF USE THEREOF |
| 07/07/1999 | EP0927257A2 Human protein kinases |
| 07/07/1999 | EP0927252A1 Antibodies against interferon alpha/beta receptor |
| 07/07/1999 | EP0927195A2 Process for producing a plasma protein-containing medicament |
| 07/07/1999 | EP0927045A2 Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 07/07/1999 | EP0927044A1 Targeted viral vectors |
| 07/07/1999 | EP0661985B1 Peptides capable of binding cd8 molecules on ctl precursors |
| 07/07/1999 | EP0637336B1 Mn gene and protein |
| 07/07/1999 | EP0570381B1 Method for immobilization of thiol compounds via activation of polymers, activated polymers, and products obtained by the method |
| 07/07/1999 | EP0537166B1 Water-soluble polypeptides having high affinity for interferons alpha and beta |
| 07/07/1999 | CN1222193A Extracellular matrix signalling molecules |
| 07/07/1999 | CN1222162A Mutated nonactivating IgG2 domains and anti-cd3 antibodies incorporating same |
| 07/07/1999 | CN1221880A In vitro method for determining presence of hepatocellular carcindoma |
| 07/07/1999 | CN1221879A In vitro method for determining presence of hepatocellular carcindoma |
| 07/06/1999 | US5919999 Enhanced transport with a plastid membrane transport protein |
| 07/06/1999 | US5919997 Transgenic mice having modified cell-cycle regulation |
| 07/06/1999 | US5919911 Monoclonal antibodies to stem cell factor receptors |
| 07/06/1999 | US5919910 Monoclonal antibodies |
| 07/06/1999 | US5919905 Cytokine designated LERK-6 |
| 07/06/1999 | US5919904 Response regulator polypeptides; screening for bactericides |
| 07/06/1999 | US5919903 Low affinity human IL-12 beta2 receptor |
| 07/06/1999 | US5919900 Modified hookworm neutrophil inhibitors |
| 07/06/1999 | US5919899 Wound healing agents for burns, injuries, and surgeries; antiulcer agents; antiinflammatory agents; markers in diagnosis of tumors |
| 07/06/1999 | US5919896 PF4A receptor |
| 07/06/1999 | US5919759 Organ transplant; wound healing agents |
| 07/06/1999 | US5919754 Method of inhibiting fibrinogen binding to endothelial cells with fibrinogen gamma chain peptides |
| 07/06/1999 | US5919693 Nucleic acid sequences of heparinases ii and iii, and transformed cells expressing heparinase ii and iii; degrade heparin and heparin sulfate |
| 07/06/1999 | US5919692 Ubiquitous ATP-sensitive potassium-channel genes |
| 07/06/1999 | US5919666 In vitro transcription of a dna sequence |
| 07/06/1999 | US5919665 A soluble endotoxin-free recombinant fusion proteins used as immunogens; antitoxins for treatment of humans and animals |
| 07/06/1999 | US5919664 For screening for antibacterial compounds |
| 07/06/1999 | US5919660 Human requiem |
| 07/06/1999 | US5919659 Polynucleotide |
| 07/06/1999 | US5919650 Introducing recombinant dna encoding an antibody/fragment that binds the protein in mammalian cells, expressing the protein intracellularly, allowing antibody to bind oncogenic protein; anticarcinogenic/antitumor agents |
| 07/06/1999 | US5919643 Methods and compositions for the use of apurinic/apyrimidinic endonucleases |
| 07/06/1999 | US5919637 Method for identifying reduced binding between GMP-140 and GMP-140 ligand |
| 07/06/1999 | US5919635 Using a genetic engineered receptor |
| 07/06/1999 | US5919634 Immunoassay using antibody or fragment which preferentially binds to crosslinked telopeptide with lysylpyridinoline or hydroxylysylpyridinoline residues; for diagnosis of osteoarthritis/rheumatoid arthritis; monitoring of treatment |
| 07/06/1999 | US5919620 Heat shock protein HSP72 of Streptococcus pneumoniae |
| 07/06/1999 | US5919617 Methods and reagents for detecting fungal pathogens in a biological sample |
| 07/06/1999 | US5919615 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them |
| 07/06/1999 | US5919461 Nonpathogenic infectious bursal disease virus and vaccine |
| 07/06/1999 | US5919459 Compositions and methods for treating cancer and hyperproliferative disorders |
| 07/06/1999 | US5919457 Immunoconjugates comprising the monoclonal antibody txu-5/b53 linked to pokeweed antiviral protein or bioactive subunits thereof are provided which are effective for the treatment of mammalian hiv infection. |
| 07/06/1999 | US5919456 IL-13 receptor specific chimeric proteins |
| 07/06/1999 | US5919454 Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications |
| 07/06/1999 | US5919453 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon |
| 07/06/1999 | US5919452 Methods of treating TNFα-mediated disease using chimeric anti-TNF antibodies |
| 07/06/1999 | US5919451 Feeding the animal feed particles having an inner core of nutrients and an outer layer containing a conjugated fatty acid or an antibody that can protect the animal from contacting diseases that can adversely affect the animal's |
| 07/06/1999 | CA2098397C Physiologically active substance designated as epimorphin, genes encoding the same, and antibodies thereto |
| 07/06/1999 | CA2000604C Process for the activation of genetechnologically produced, biologically-active proteins expressed in prokaryotes |
| 07/06/1999 | CA1340635C Attachment of compounds to polymeric particles using dication ethers and a kit containing same |
| 07/05/1999 | WO1999038976A2 Human growth factor homologs |
| 07/05/1999 | CA2317812A1 Human growth factor homologs |
| 07/01/1999 | WO1999032645A1 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 07/01/1999 | WO1999032644A2 Prostate cancer gene |
| 07/01/1999 | WO1999032637A1 Human signal transduction serine/threonine kinase |
| 07/01/1999 | WO1999032635A1 Acetyl-coa-carboxylase from candida albicans |
| 07/01/1999 | WO1999032634A2 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | WO1999032630A1 Herbicide binding proteins and transgenic plants containing them |
| 07/01/1999 | WO1999032629A1 Tigirr dna and polypeptides |
| 07/01/1999 | WO1999032626A1 Sigirr dna and polypeptides |
| 07/01/1999 | WO1999032625A2 Nucleotide and protein sequence of mammastatin and methods of use |
| 07/01/1999 | WO1999032623A1 Human sel-10 polypeptides and polynucleotides that encode them |
| 07/01/1999 | WO1999032620A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | WO1999032615A1 Brain or heart cyclic nucleotide gated ion channel compounds and uses thereof |
| 07/01/1999 | WO1999032610A1 Human nucleotide pyrophosphohydrolase-2 |
| 07/01/1999 | WO1999032604A1 Linoleate isomerase |
| 07/01/1999 | WO1999032520A1 Method for quantitating denatured ldls |
| 07/01/1999 | WO1999032519A1 Novel g protein-coupled receptor |
| 07/01/1999 | WO1999032518A1 A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof |